Sunday, 25 January 2009

Dextrose/Fructose/Phosphoric Acid Solution


Pronunciation: DEX-tros/FRUK-tose/fos-FOR-ik AS-id
Generic Name: Dextrose/Fructose/Phosphoric Acid
Brand Name: Examples include Emetrol and Nausetrol

This product contains sugar and should not be taken by diabetic patients except under the advice and supervision of a health care provider.





Dextrose/Fructose/Phosphoric Acid Solution is used for:

Treating nausea and vomiting.


Dextrose/Fructose/Phosphoric Acid Solution is an antiemetic combination. It is unknown exactly how Dextrose/Fructose/Phosphoric Acid Solution works.


Do NOT use Dextrose/Fructose/Phosphoric Acid Solution if:


  • you are allergic to any ingredient in Dextrose/Fructose/Phosphoric Acid Solution

  • you have hereditary fructose intolerance (HFI)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Dextrose/Fructose/Phosphoric Acid Solution:


Some medical conditions may interact with Dextrose/Fructose/Phosphoric Acid Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have diabetes

Some MEDICINES MAY INTERACT with Dextrose/Fructose/Phosphoric Acid Solution. However, no specific interactions with Dextrose/Fructose/Phosphoric Acid Solution are known at this time.


This may not be a complete list of all interactions that may occur. Ask your health care provider if Dextrose/Fructose/Phosphoric Acid Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Dextrose/Fructose/Phosphoric Acid Solution:


Use Dextrose/Fructose/Phosphoric Acid Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Dextrose/Fructose/Phosphoric Acid Solution may be taken with or without food.

  • Do not mix Dextrose/Fructose/Phosphoric Acid Solution in any other liquid before taking.

  • Do not drink any other fluids right before or for 15 minutes after taking a dose of Dextrose/Fructose/Phosphoric Acid Solution.

  • Take Dextrose/Fructose/Phosphoric Acid Solution every 15 minutes or until symptoms go away.

  • Do not take Dextrose/Fructose/Phosphoric Acid Solution for more than 1 hour (5 doses) without contacting your doctor.

  • If you miss a dose of Dextrose/Fructose/Phosphoric Acid Solution, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dextrose/Fructose/Phosphoric Acid Solution.



Important safety information:


  • If upset stomach continues or recurs often, contact your doctor.

  • Diabetes patients - Do not use Dextrose/Fructose/Phosphoric Acid Solution unless instructed to do so by your doctor.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Dextrose/Fructose/Phosphoric Acid Solution, discuss with your doctor the benefits and risks of using Dextrose/Fructose/Phosphoric Acid Solution during pregnancy. If you are or will be breast-feeding while you are using Dextrose/Fructose/Phosphoric Acid Solution, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Dextrose/Fructose/Phosphoric Acid Solution:


All medicines may cause side effects, but many people have no, or minor, side effects. When used in small doses, no COMMON side effects have been reported with this product. Seek medical attention right away if any of these SEVERE side effects occur:



Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Dextrose/Fructose/Phosphoric Acid Solution:

Store Dextrose/Fructose/Phosphoric Acid Solution at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dextrose/Fructose/Phosphoric Acid Solution out of the reach of children and away from pets.


General information:


  • If you have any questions about Dextrose/Fructose/Phosphoric Acid Solution, please talk with your doctor, pharmacist, or other health care provider.

  • Dextrose/Fructose/Phosphoric Acid Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dextrose/Fructose/Phosphoric Acid Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dextrose/Fructose/Phosphoric Acid resources


  • Dextrose/Fructose/Phosphoric Acid Use in Pregnancy & Breastfeeding
  • Dextrose/Fructose/Phosphoric Acid Support Group
  • 2 Reviews for Dextrose/Fructose/Phosphoric Acid - Add your own review/rating


Compare Dextrose/Fructose/Phosphoric Acid with other medications


  • Nausea/Vomiting

Wednesday, 21 January 2009

Doxitab




Doxitab may be available in the countries listed below.


Ingredient matches for Doxitab



Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxitab in the following countries:


  • South Africa

International Drug Name Search

Tuesday, 20 January 2009

Diaretyl




Diaretyl may be available in the countries listed below.


Ingredient matches for Diaretyl



Loperamide

Loperamide is reported as an ingredient of Diaretyl in the following countries:


  • Tunisia

International Drug Name Search

Friday, 16 January 2009

Glucosamin Orion




Glucosamin Orion may be available in the countries listed below.


Ingredient matches for Glucosamin Orion



Glucosamine

Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Glucosamin Orion in the following countries:


  • Finland

International Drug Name Search

Wednesday, 14 January 2009

Midazolam Hexal




Midazolam Hexal may be available in the countries listed below.


Ingredient matches for Midazolam Hexal



Midazolam

Midazolam is reported as an ingredient of Midazolam Hexal in the following countries:


  • Germany

Midazolam hydrochloride (a derivative of Midazolam) is reported as an ingredient of Midazolam Hexal in the following countries:


  • Germany

International Drug Name Search

Tuesday, 6 January 2009

Rowasa


Rowasa is a brand name of mesalamine, approved by the FDA in the following formulation(s):


ROWASA (mesalamine - enema; rectal)



  • Manufacturer: MEDA PHARMS

    Approval date: December 24, 1987

    Strength(s): 4GM/60ML [RLD][AB]

Has a generic version of Rowasa been approved?


Yes. The following products are equivalent to Rowasa:


mesalamine enema; rectal



  • Manufacturer: PERRIGO ISRAEL

    Approval date: September 17, 2004

    Strength(s): 4GM/60ML [AB]


  • Manufacturer: TEVA

    Approval date: September 30, 2004

    Strength(s): 4GM/60ML [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rowasa. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Rowasa.

See also...

  • Rowasa Enema Consumer Information (Wolters Kluwer)
  • Rowasa rectal Consumer Information (Cerner Multum)
  • Rowasa Advanced Consumer Information (Micromedex)
  • Mesalamine Controlled-Release Capsules Consumer Information (Wolters Kluwer)
  • Mesalamine Delayed-Release Tablets Consumer Information (Wolters Kluwer)
  • Mesalamine Enema Consumer Information (Wolters Kluwer)
  • Mesalamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Mesalamine Suppositories Consumer Information (Wolters Kluwer)
  • Mesalamine Consumer Information (Cerner Multum)
  • Mesalamine rectal Consumer Information (Cerner Multum)
  • Mesalamine Advanced Consumer Information (Micromedex)
  • Mesalamine Rectal Advanced Consumer Information (Micromedex)
  • SfRowasa Advanced Consumer Information (Micromedex)
  • Mesalamine AHFS DI Monographs (ASHP)

Sunday, 4 January 2009

Oxifenbutazone




Oxifenbutazone may be available in the countries listed below.


Ingredient matches for Oxifenbutazone



Oxyphenbutazone

Oxifenbutazone (DCIT) is also known as Oxyphenbutazone (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 3 January 2009

Omeprazol Mede




Omeprazol Mede may be available in the countries listed below.


Ingredient matches for Omeprazol Mede



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Mede in the following countries:


  • Spain

International Drug Name Search

Friday, 2 January 2009

Solrin




Solrin may be available in the countries listed below.


Ingredient matches for Solrin



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Solrin in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, 1 January 2009

Ticlopidina Bluepharma




Ticlopidina Bluepharma may be available in the countries listed below.


Ingredient matches for Ticlopidina Bluepharma



Ticlopidine

Ticlopidine is reported as an ingredient of Ticlopidina Bluepharma in the following countries:


  • Portugal

International Drug Name Search

Cefazolin for Injection




Ingredient matches for Cefazolin for Injection



Cefazolin

Cefazolin sodium salt (a derivative of Cefazolin) is reported as an ingredient of Cefazolin for Injection in the following countries:


  • United States

International Drug Name Search

Albuterol Sulfate and Ipratropium Bromide




Ingredient matches for Albuterol Sulfate and Ipratropium Bromide



Ipratropium

Ipratropium Bromide is reported as an ingredient of Albuterol Sulfate and Ipratropium Bromide in the following countries:


  • United States

Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Albuterol Sulfate and Ipratropium Bromide in the following countries:


  • United States

International Drug Name Search